EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Unlocking the Therapeutic Potential of DNA-PKcs in Cancer: Comprehensive Insights into Mechanisms and Clinical Applications

Tong Zheng iD, Chao Sun iD, Cijun Yun iD, Hui Wang iD, Xiongxiong Liu iD

Cancers · 26.08.2025 · 17 (17) · 2787

DOI: 10.3390/cancers17172787 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cancers, online erschienen am 26.08.2025. Verfasst von Tong Zheng und 4 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Modern Physics, Chinese Academy of Sciences, Lanzhou 730000, China. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 185 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation of Gansu Province, the Construction and Talent Management of Isotope Manufacturing Innovation Center of Gansu Province, Isotope Laboratory Self deployment Project of Gansu Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cancer remains one of the most pressing global health challenges, with current therapies often hindered by limited efficacy and the emergence of resistance. The DNA-dependent protein kinase catalytic subunit (DNA-PKcs), a key regulator of DNA repair and cell cycle progression, plays a critical role in maintaining genomic stability, and growing evidence indicates its dysregulation in various cancers, with overexpression frequently associated with aggressive tumor phenotypes. To evaluate DNA-PKcs as a therapeutic target, we systematically analyzed literature from PubMed and Web of Science (2000–2024) using keywords including DNA-PKcs, targeted therapy, DNA repair, and tumor resistance following PRISMA guidelines, with 185 of 1250 initial records meeting inclusion criteria after screening. The review explores the multifaceted roles of DNA-PKcs in tumor biology and resistance mechanisms, evaluates the current landscape of DNA-PKcs inhibitors, including their clinical progress and combination strategies with radiotherapy and chemotherapy, and discusses key determinants of therapeutic efficacy, such as tumor type and mutation status. Additionally, it uniquely integrates emerging insights into the roles of DNA-PKcs in immunomodulation and metabolism, critically assesses next-generation inhibitors, and proposes strategies to address remaining challenges. Through this comprehensive analysis, we highlight the therapeutic potential of DNA-PKcs inhibition as a novel strategy to circumvent treatment resistance, providing innovative insights for optimizing cancer management, especially for aggressive tumor subtypes, thereby advancing drug discovery efforts and paving the way for more effective therapeutic interventions in clinical practice.

Schlagwörter

Stichwörter der Autor:innen

DNA repairDNA-PKcstargeted therapytumor resistance

Autor:innen und Institutionen

  • Institute of Modern Physics, Chinese Academy of Sciences, Lanzhou 730000, China.
  • Gansu Provincial Isotope Laboratory, Lanzhou 730300, China.
  • University of Chinese Academy of Sciences, Beijing 100049, China.
  • Advanced Energy Science and Technology Guangdong Laboratory, Huizhou 516029, China.

ORCID-Profile: Tong Zheng, Chao Sun, Cijun Yun, Hui Wang, Xiongxiong Liu

Förderung

  • Natural Science Foundation of Gansu Province
  • the Construction and Talent Management of Isotope Manufacturing Innovation Center of Gansu Province
  • Isotope Laboratory Self deployment Project of Gansu Province
  • BR Program of Chinese Academy of Sciences
  • Construction and Talent Management of Isotope Manufacturing Innovation Center of Gansu Province

Zitieren

APA

Zheng, T., Sun, C., Yun, C., Wang, H., & Liu, X. (2025). Unlocking the Therapeutic Potential of DNA-PKcs in Cancer: Comprehensive Insights into Mechanisms and Clinical Applications. Cancers, 17(17), 2787. https://doi.org/10.3390/cancers17172787

Vancouver

Zheng T, Sun C, Yun C, Wang H, Liu X. Unlocking the Therapeutic Potential of DNA-PKcs in Cancer: Comprehensive Insights into Mechanisms and Clinical Applications. Cancers. 2025;17(17):2787. doi:10.3390/cancers17172787

BibTeX
@article{Zheng2025,
  author = {Zheng, Tong and Sun, Chao and Yun, Cijun and Wang, Hui and Liu, Xiongxiong},
  title = {Unlocking the Therapeutic Potential of DNA-PKcs in Cancer: Comprehensive Insights into Mechanisms and Clinical Applications},
  journal = {Cancers},
  year = {2025},
  volume = {17},
  number = {17},
  pages = {2787},
  doi = {10.3390/cancers17172787}
}
Kostenlos starten →